Del Mar, CA, United States of America

G Michael Iverson


Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2000-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of G Michael Iverson

Introduction: G Michael Iverson, hailing from Del Mar, California, has made significant strides in the field of autoimmunity through his innovative inventions. With a portfolio of five patents, his work primarily focuses on methods for diagnosing acute atherosclerotic syndrome, showcasing his dedication to advancing medical diagnostics.

Latest Patents: Among G Michael Iverson's recent patents is his work on "Compositions and methods for diagnosing patients with acute atherosclerotic syndrome." This invention pertains to the detection of autoantibodies to domain 4 of beta 2-glycoprotein I (β-GPI), which serve as an indicator for atherosclerosis. His contributions are crucial in providing new avenues for diagnosing and managing cardiovascular diseases.

Career Highlights: Throughout his career, Iverson has been associated with notable companies, including La Jolla Pharmaceutical Company and Inova Diagnostics, Inc. His efforts in these organizations have helped advance research in immunology and cardiovascular health.

Collaborations: Iverson has collaborated with esteemed colleagues such as Paul A Barstad and Walter L Binder, working alongside them to push the boundaries of current medical research. These partnerships have fueled innovation and have led to significant advancements in the diagnostic field.

Conclusion: G Michael Iverson stands out as a prominent inventor in the realm of autoimmunity and cardiovascular diagnostics. His patents not only demonstrate his innovative spirit but also his commitment to improving patient outcomes through science and research. As he continues to contribute to the medical field, his work holds the promise of shaping future diagnostic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…